International Graphite Limited (IG6.AX)
AUD 0.04
(-11.11%)
AUD 0.04
(-11.11%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 4263.00 | - | - | - |
| Cost of Revenue | 194.45 Thousand | 73.37 Thousand | 34.54 Thousand | 5756.00 | - | - |
| Gross Profit | -194.45 Thousand | -73.37 Thousand | -30.28 Thousand | -5756.00 | - | - |
| Operating Expenses | 3.93 Million | 2.51 Million | 2.06 Million | 2.09 Million | 1.6 Million | 1.12 Million |
| Selling, General and Administrative Expenses | 3.8 Million | 2.51 Million | 1.8 Million | 2.09 Million | 1.6 Million | 1.12 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 13.27 Thousand | - | - | - | - |
| Cost and Expenses | 3.93 Million | 2.58 Million | 2.06 Million | 2.09 Million | 1.6 Million | 1.12 Million |
| Operating Income | -3.93 Million | -2.58 Million | -2.09 Million | -2.09 Million | -1.6 Million | -1.12 Million |
| Interest Expense | - | - | - | 451.00 | - | - |
| Income Tax Expense | - | 4.00 | -193.94 Thousand | 4.00 | -162.05 Thousand | -145.59 Thousand |
| Earnings before Tax | -4.01 Million | -2.53 Million | -2.05 Million | -2.09 Million | -1.6 Million | -1.12 Million |
| Net Income | -4.01 Million | -2.53 Million | -2.05 Million | -2.09 Million | -1.44 Million | -975.7 Thousand |
| Earnings Per Share Basic | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 170.18 Million | 165.15 Million | 165.15 Million | 161.15 Million | 165.15 Million | 165.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 170.18 Million | 165.15 Million | 165.15 Million | 161.15 Million | 165.15 Million | 165.15 Million |
| Gross Margin | - | - | -7.10 | - | - | - |
| EBIT Margin | - | - | -483.34 | - | - | - |
| Profit Margin | - | - | -482.28 | - | - | - |
| EBITDA | -3.73 Million | -2.45 Million | -2.02 Million | -2.08 Million | -161.91 Thousand | - |
| Earnings Before Tax Margin | - | - | -491.44 | - | - | - |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 152.59 Thousand | - | 41.85 Thousand | - | 22.6 Thousand | 73.37 Thousand |
| Gross Profit | -152.59 Thousand | - | -41.85 Thousand | - | -22.6 Thousand | -73.37 Thousand |
| Operating Expenses | 983.69 | 983.69 | 981.72 | 981.72 | 1.58 Million | 2.51 Million |
| Selling, General and Administrative Expenses | 919.61 | 919.61 | 981.72 | 981.72 | 1.58 Million | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 64.08 | 64.08 | - | - | - | 13.27 Thousand |
| Cost and Expenses | 983.69 | 983.69 | 981.72 | 981.72 | 1.6 Million | 2.58 Million |
| Operating Income | -983.69 | -983.69 | -981.72 | -981.72 | -1.6 Million | -2.58 Million |
| Interest Expense | - | - | 12.23 Thousand | - | - | - |
| Income Tax Expense | -33.14 | -33.14 | -3.00 | - | -4.00 | 4.00 |
| Earnings before Tax | -1027.24 | -1027.24 | -981.50 | -981.50 | -1.58 Million | -2.53 Million |
| Net Income | -1027.24 | -1027.24 | -981.50 | -981.50 | -1.58 Million | -2.53 Million |
| Earnings Per Share Basic | - | -0.01 | -0.01 | -0.01 | -0.01 | - |
| Earnings Per Share Diluted | - | -0.01 | -0.01 | -0.01 | -0.01 | - |
| Weighted Average Shares Outstanding | 174.01 Million | 174.01 Million | 166.35 Million | 166.35 Million | 165.15 Million | 165.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 174.01 Million | 174.01 Million | 166.35 Million | 166.35 Million | 165.15 Million | 165.15 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -983.41 | -1005.77 | -970.66 | -970.66 | -1.58 Million | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
ALGWF
EXMT
J
JAGSNPHARM
6262
WEWIN